oxycodone hcl 50 mg/1 ml medsurge oxycodone hydrochloride 50 mg/1 ml solution for injection ampoule
medsurge pharma pty ltd - oxycodone hydrochloride, quantity: 50 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; sodium chloride; hydrochloric acid; sodium hydroxide; sodium citrate dihydrate; water for injections - oxycodone hcl medsurge solution for injection or infusion is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.
amitriptyline hydrochloride 50 mg/ 5 ml oral solution
pinewood laboratories ltd, - amitriptyline hydrochloride - oral solution - 50 mg/5ml - non-selective monoamine reuptake inhibitors; amitriptyline
epilim syrup
sanofi-aventis australia pty ltd - sodium valproate, quantity: 40 mg/ml - oral liquid - excipient ingredients: sorbitol; sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; saccharin sodium; brilliant scarlet 4r; purified water; sucrose; flavour - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate
neoral capsule
novartis pharmaceuticals canada inc - cyclosporine - capsule - 50mg - cyclosporine 50mg - immunosuppressive agents
ran-clarithromycin powder for suspension
sun pharma canada inc - clarithromycin - powder for suspension - 250mg - clarithromycin 250mg - other macrolides
taro-clarithromycin powder for suspension
taro pharmaceuticals inc - clarithromycin - powder for suspension - 250mg - clarithromycin 250mg - other macrolides
klaricid paediatric 250mg/5ml oral suspension
viatris uk healthcare ltd - clarithromycin - oral suspension - 50mg/1ml
cellcept mycophenolate mofetil 200mg/ml suspension bottle
roche products pty ltd - mycophenolate mofetil, quantity: 200 mg/ml - suspension - excipient ingredients: citric acid; xanthan gum; aspartame; methyl hydroxybenzoate; purified water; silicon dioxide; sorbitol; lecithin; sodium citrate dihydrate; flavour - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.
epilim liquid
pharmacy retailing (nz) ltd t/a healthcare logistics - sodium valproate 40 mg/ml; - oral solution - 200 mg/5ml - active: sodium valproate 40 mg/ml excipient: cherry flavour 17.40.0740 citric acid hyetellose ponceau 4r purified water saccharin sodium sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate sorbitol - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.
klacid
viatris limited - clarithromycin 250mg; ; clarithromycin 250mg - film coated tablet - 250 mg - active: clarithromycin 250mg excipient: croscarmellose sodium hydrated silica hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc quinoline yellow sorbic acid sorbitan oleate starch stearic acid titanium dioxide vanillin active: clarithromycin 250mg excipient: colloidal silicon dioxide croscarmellose sodium ethanol hyprolose hypromellose magnesium stearate microcrystalline cellulose povidone propylene glycol purified talc purified water quinoline yellow sorbic acid sorbitan oleate starch stearic acid titanium dioxide vanillin - klacid tablets are indicated for treatment of infections caused by susceptible organisms. such infections include: · respiratory tract infections including bronchitis, pneumonia, tonsillitis, sinusitis and pharyngitis. · skin and soft tissue infections such as folliculitis, cellulitis and erysipelas. · disseminated or localized mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localized infections due to mycobacterium chelonae, mycobacterium fortuitum, or mycobacterium kansasii. · prevention of disseminated mycobacterium avium complex infection in hiv-infected patients with cd4 lymphocyte counts less than or equal to 100/mm3. · clarithromycin in the presence of acid suppression is indicated for the treatment of duodenal ulcer and in reducing the rate of ulcer recurrence.